Skip to main content

Advertisement

SpringerLink
Log in

Breakthrough Fusarium solani infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxis

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Kristensen R, Torp M, Kosiak B, Holst-Jensen A (2005) Phylogeny and toxigenic potential is correlated in Fusarium species as revealed by partial translation elongation factor 1 alpha gene sequences. Mycol Res 109(Pt 2):173–186

    Article  CAS  PubMed  Google Scholar 

  2. Liu JY, Chen WT, Ko BS, Yao M, Hsueh PR, Hsiao CH, Kuo YM, Chen YC (2011) Combination antifungal therapy for disseminated fusariosis in immunocompromised patients : a case report and literature review. Med Mycol 49(8):872–878

    CAS  PubMed  Google Scholar 

  3. Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356(4):348–359

    Article  CAS  PubMed  Google Scholar 

  4. Bose P, Parekh HD, Holter JL, Greenfield RA (2011) Disseminated fusariosis occurring in two patients despite posaconazole prophylaxis. J Clin Microbiol 49(4):1674–1675

    Article  PubMed Central  PubMed  Google Scholar 

  5. Ananda-Rajah MR, Grigg A, Downey MT, Bajel A, Spelman T, Cheng A, Thursky KT, Vincent J, Slavin MA (2012) Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period. Haematologica 97(3):459–463

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Vehreschild JJ, Rüping MJ, Wisplinghoff H, Farowski F, Steinbach A, Sims R, Stollorz A, Kreuzer KA, Hallek M, Bangard C, Cornely OA (2010) Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6-year experience of the Cologne AML cohort. J Antimicrob Chemother 65(7):1466–1471

    Article  CAS  PubMed  Google Scholar 

  7. Auberger J, Lass-Flörl C, Aigner M, Clausen J, Gastl G, Nachbaur D (2012) Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. J Antimicrob Chemother 67(9):2268–2273

    Article  CAS  PubMed  Google Scholar 

  8. Girmenia C, Frustaci AM, Gentile G, Minotti C, Cartoni C, Capria S, Trisolini SM, Matturro A, Loglisci G, Latagliata R, Breccia M, Meloni G, Alimena G, Foà R, Micozzi A (2012) Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience. Haematologica 97(4):560–567

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Lekakis LJ, Lawson A, Prante J, Ribes J, Davis GJ, Monohan G, Baraboutis IG, Skoutelis AT, Howard DS (2009) Fatal rhizopus pneumonia in allogeneic stem cell transplant patients despite posaconazole prophylaxis: two cases and review of the literature. Biol Blood Marrow Transplant 15(8):991–995

    Article  PubMed  Google Scholar 

  10. Nucci M, Anaissie E (2007) Fusarium infections in immunocompromised patients. Clin Microbiol Rev 20(4):695–704

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have declared no conflicts of interest.

Author information

Authors and Affiliations

  1. Division of Hematology–Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, 100 Tzyou 1st Road, 807, Kaohsiung, Taiwan

    Cheng-Han Wu, Hui-Hua Hsiao, Ta-Chih Liu, Sheng-Fung Lin, Chao-Sung Chang, Jui-Feng Hsu & Yi-Chang Liu

  2. Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

    Po-Liang Lu

  3. Department of Internal Medicine, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

    Po-Liang Lu, Hui-Hua Hsiao, Ta-Chih Liu, Sheng-Fung Lin, Chao-Sung Chang & Yi-Chang Liu

Authors
  1. Cheng-Han Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Po-Liang Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hui-Hua Hsiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ta-Chih Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sheng-Fung Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chao-Sung Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jui-Feng Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yi-Chang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yi-Chang Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, CH., Lu, PL., Hsiao, HH. et al. Breakthrough Fusarium solani infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxis. Ann Hematol 93, 1079–1081 (2014). https://doi.org/10.1007/s00277-013-1943-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-013-1943-6

Keywords

Search

Navigation